A highly potent South African green tea extract has been voted among the world’s top new products at one of Europe’s most prestigious natural health trade shows.
Produced in the foothills of the Drakensberg in Mpumalanga and developed by scientists and medical experts, polyphenol-rich Origine 8 was voted as one of the top three out of 330 new health products in the Judges Choice Awards at the Natural & Organic Products Europe trade show (NOPE) in London.
Origine 8 is produced from live green tea within six hours of harvest through a patented Phytofare extraction process at the Senteeko Tea Estate in Mpumalanga.
The entire process from farming to harvesting to extraction happens at one location, ensuring the highest levels of integrity and efficacy of the plant nutrients. It is further enhanced by a world-renowned, clinically-proven nutraceutical delivery system, Liposome, which promotes bioavailability and stability of the extract.
A clinical study by South Africa’s University of the North West found that the catechins from a single dose of Origine 8 stayed in the bloodstream for 24 hours compared to six hours in the case of regular green tea extracts.
Spokesperson for the awards, Dominic Roberjot, said: “I think it’s a truly outstanding product. I am very impressed. It is right up there with the best and I believe it has huge potential for growth in Europe and the UK.”
Kevin Coyne, founder and CEO of Coyne Healthcare which developed Origine 8 said the product was a “true breakthrough in not only potent green tea supplementation but in overall health.”